Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis

Rich, Devra P., Couture, Larry A., Cardoza, Lisa M., Guiggio, Vicki M., Armentano, Donna, Espino, Pearl C., Hehir, Kathleen, Welsh, Michael J., Smith, Alan E., Gregory, Richard J.·1993·Human Gene Therapy

Abstract

A new adenovirus-based vector (Ad2/CFTR-1) has been constructed in which the cDNA encoding the cystic fibrosis transmembrane conductance regulator (CFTR), the cystic fibrosis (CF) gene product, replaces the early region 1 coding sequences, E1a and E1b. The virus retains the E3 region. Ad2/CFTR-1 and a related construct encoding β-galactosidase replicate in human 293 cells which provide E1 gene functions in trans. Replication of these recombinant viruses was not detected in a variety of other cells, although very limited viral DNA synthesis and transcription from the E4 and L5 regions could be measured. These E1-deletion vectors were also deficient in cellular transformation, shut-off of host cell protein synthesis, and production of cytopathic effects, even at high multiplicities of infection. Ad2/CFTR-1 produced CFTR protein in a variety of cells including airway epithelia from CF patients. Expression of functional CFTR protein in a CF airway epithelial monolayer was detected by correction of the CI¯ transport defect characteristic of CF. Surprisingly low multiplicities of infection (0.1 moi) were sufficient to generate CFTR Cl¯ current across a CF epithelial monolayer in vitro. These data, together with the lack of obvious toxicity, suggest that Ad2/CFTR-1 should be suitable for CF gene therapy. Gene therapy for cystic flbrosis (CF) will likely require delivery of a normal CF gene to the airway epithelia of CF patients. Here we report the construction of a new adenovirus-based vector, Ad2/CFTR-1, designed for this purpose. This vector is derived from adenovirus type 2 and lacks most of the E1 region coding sequences. In place of the E1 sequence, cDNA encoding CFTR, the CF gene product, is substituted. Unlike many E1-deletion vectors, the construct retains the entire E3 region. We present data on some aspects of the viral life cycle in tissue culture cells and demonstrate the ability of this vector to complement the defect in transepithelial Cl¯ secretion characteristic of human CF airway epithelial cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.1993.4.4-461

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 162

Metadata

Authors
Rich, D. P., Couture, L. A., Cardoza, L. M., Guiggio, V. M., Armentano, D., Espino, P. C., Hehir, K., Welsh, M. J., Smith, A. E., & Gregory, R. J.
Venue
Human Gene Therapy
Published
1993-08
Volume
4
Issue
4
Pages
461-476
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2020301682
Cited by
162
References
3
FWCI
12.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis. https://app.cochat.ai/papers/10.1089/hum.1993.4.4-461
The paper
Rich, D. P., Couture, L. A., Cardoza, L. M., Guiggio, V. M., Armentano, D., Espino, P. C., Hehir, K., Welsh, M. J., Smith, A. E., & Gregory, R. J. (1993). Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis. Human Gene Therapy. https://doi.org/10.1089/hum.1993.4.4-461

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.